Literature DB >> 8118385

Reliability of measurements of total, protein-bound, and unbound estradiol in serum.

P Toniolo1, K L Koenig, B S Pasternack, S Banerjee, C Rosenberg, R E Shore, P Strax, M Levitz.   

Abstract

Estradiol (E2) circulates in the blood in three states: unbound (U-E2), bound to sex-hormone binding globulin (SHBG-E2), and bound to albumin. There is evidence to support the concept that only U-E2 and albumin-bound E2, are bioavailable (i.e., rapidly extracted by tissues). A case-control study nested within a large cohort of women, in which we are examining the effect of estrogens on breast cancer risk, offered the opportunity to assess the reliability of measurements of E2, the percentage of SHBG-E2, and the percentage of U-E2 based on multiple annual serum specimens. Long-term (1-2 year) reliability, as estimated by the intraclass correlation coefficient, was assessed in a subgroup of 71 premenopausal and 77 postmenopausal controls for whom two or three serum specimens were assayed. In postmenopausal women the intraclass correlation coefficient for a single measurement of total E2 was only 0.51. As for the percentage of SHBG-E2, intraclass correlation coefficients were 0.83 and 0.94, and for U-E2, 0.72 and 0.77 in the premenopausal and postmenopausal groups, respectively. These data suggest that, whereas single determinations of total E2 are insufficient to reliably estimate a woman's true mean level, a single measurement of the percentage of SHBG-E2 or U-E2 is adequate to assess bioavailability of E2 in an epidemiological study, irrespective of day of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118385

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

1.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

2.  Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.

Authors:  D A Kossman; N I Williams; S M Domchek; M S Kurzer; J E Stopfer; K H Schmitz
Journal:  J Appl Physiol (1985)       Date:  2011-09-08

3.  Reproducibility of serum cytokines and growth factors.

Authors:  Yian Gu; Anne Zeleniuch-Jacquotte; Faina Linkov; Karen L Koenig; Mengling Liu; Lyudmila Velikokhatnaya; Roy E Shore; Adele Marrangoni; Paolo Toniolo; Anna E Lokshin; Alan A Arslan
Journal:  Cytokine       Date:  2008-12-05       Impact factor: 3.861

4.  Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Anne Zeleniuch-Jacquotte; Lisa Gallicchio; Virginia Hartmuller; Kathy J Helzlsouer; Marjorie L McCullough; V Wendy Setiawan; Xiao-Ou Shu; Stephanie J Weinstein; Jocelyn M Weiss; Alan A Arslan; Immaculata De Vivo; Yu-Tang Gao; Richard B Hayes; Brian E Henderson; Ronald L Horst; Karen L Koenig; Alpa V Patel; Mark P Purdue; Kirk Snyder; Emily Steplowski; Kai Yu; Wei Zheng; Susan E Hankinson
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

5.  Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.

Authors:  Roksana Karim; Howard N Hodis; Frank Z Stanczyk; Rogerio A Lobo; Wendy J Mack
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

6.  Temporal reliability of cytokines and growth factors in EDTA plasma.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Annika Idahl; Göran Hallmans; Karen L Koenig; Adele M Marrangoni; Brian M Nolen; Nina Ohlson; Anne Zeleniuch-Jacquotte; Eva Lundin
Journal:  BMC Res Notes       Date:  2010-11-13

7.  Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.

Authors:  R G Ziegler; S C Rossi; T R Fears; H L Bradlow; H Adlercreutz; D Sepkovic; P Kiuru; K Wahala; J B Vaught; J L Donaldson; R T Falk; C M Fillmore; P K Siiteri; R N Hoover; M H Gail
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study.

Authors:  A Zeleniuch-Jacquotte; A Akhmedkhanov; I Kato; K L Koenig; R E Shore; M Y Kim; M Levitz; K R Mittal; U Raju; S Banerjee; P Toniolo
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

9.  The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women.

Authors:  Andrew E Williams; Gertraud Maskarinec; Adrian A Franke; Frank Z Stanczyk
Journal:  BMC Womens Health       Date:  2002-12-23       Impact factor: 2.809

10.  Does place of birth influence endogenous hormone levels in Asian-American women?

Authors:  R T Falk; T R Fears; R N Hoover; M C Pike; A H Wu; A M Y Nomura; L N Kolonel; D W West; R G Ziegler
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.